At the same time, GLP-1 drugs have turned into a real tool for treating obstructive sleep apnea in obese patients
Results: Several studies show that GLP-1RAs, particularly liraglutide and semaglutide, improve PsO severity, metabolic parameters, and inflammatory markers
For this reason, these proteins represent potential targets for anti-cancer therapy and should be added to the existing list, including sugar and amino acid transporters, which are already considered druggable targets
Emerging evidence suggests sex may matter in both efficacy and tolerability
Once these fatty acids are safely inside the mitochondria, they undergo a process called oxidation
Such growth of diabetes-treatment-nave patients is partly a reflection of GLP-1s growing use as a first-line treatment in diabetes, but also demand for the weight loss benefits alone